Uncovering Hidden Arrhythmias
HeartBug enables earlier and more accurate detection of intermittent arrhythmias through 28-day continuous ECG monitoring — empowering clinicians to initiate timely treatment, reduce stroke risk, and improve long-term cardiovascular outcomes.
Higher Diagnostic Yield
Capture elusive arrhythmias that traditional 24-hour Holter monitors leave behind. Definitive data for confident diagnosis.
Stroke Prevention
Earlier AF detection leads to earlier anticoagulation, directly reducing the risk of stroke and severe cardiac events.
Remote-First Care
Bring hospital-grade continuous monitoring into the patient's home, streamlining workflows and reducing unnecessary visits.
Definitive Diagnostic Certainty
HeartBug provides Australia’s only 28-day continuous ECG, giving clinicians the definitive data needed to confidently diagnose complex arrhythmias, while giving patients the peace of mind they deserve.
- ■ Continuous Wearable Design
- ■ Scalable Remote Infrastructure
- ■ Expert Review & Reporting
Redefining the Diagnostic Pathway
As Australia’s only provider of 28-day continuous ECG monitoring, HeartBug sets a new standard in ambulatory cardiac diagnostics — delivering superior diagnostic yield while reducing repeat testing, hospital presentations, and clinical uncertainty.
For Clinicians
Greater Diagnostic Confidence: End the frustrating cycle of inconclusive short-term tests. Reduced variability in diagnostic pathways.
Faster Time to Diagnosis: Remote monitoring with expert review ensures you get actionable data without increasing your clinical burden.
For Health Systems
System-Level Efficiency: Reduced in-hospital visits and optimized specialist capacity. A scalable solution for ageing populations.
Economic Benefits: Fewer repeat tests and delayed diagnoses mean better resource allocation across the healthcare network.